Understanding Your Diagnosis: Mal de Meleda
At a Glance
Mal de Meleda is a rare inherited skin condition that causes thickening on the palms and soles, often extending onto the backs of the hands and feet. It usually begins in infancy, may progress during childhood, and can cause sweating, painful cracks, and limited movement.
Receiving a diagnosis of transgrediens et progrediens palmoplantar keratoderma—most commonly known as Mal de Meleda—can feel overwhelming. Because this condition is exceptionally rare, you may find that many general practitioners have never encountered it before [1]. This page is designed to help you understand the nature of the condition, what the name means for your future, and how to navigate the journey ahead.
Defining the Condition
The name itself is a literal description of how the condition behaves. These Latin terms help doctors categorize the specific way the skin changes [1][2]:
- Palmoplantar Keratoderma (PPK): A group of conditions characterized by the thickening (keratoderma) of the skin on the palms of the hands (palmo-) and the soles of the feet (-plantar).
- Transgrediens: This means “crossing margins.” In Mal de Meleda, the skin thickening does not stop at the edges of the palms or soles. Instead, it “crosses over” onto the backs of the hands, the tops of the feet, and sometimes the wrists or ankles [1].
- Progrediens: This means “progressive.” The condition usually begins in infancy and often becomes more pronounced or covers a larger area during childhood, though adult stability and progression rates vary greatly among individuals [2].
Understanding Rarity and Inheritance
Mal de Meleda is considered a very rare disease, with an estimated prevalence of approximately 1 in 100,000 people [1][3]. It is typically inherited in an autosomal recessive pattern. This means that if both biological parents are carriers of a single mutated gene, each pregnancy has a 25% chance of being affected, a 50% chance of being a carrier like the parents, and a 25% chance of inheriting neither familial variant. The risk for an affected person’s children depends entirely on their partner’s carrier status [4].
Because it is so rare, it is common for families to face a “diagnostic odyssey”—a long period of seeing different doctors before receiving the correct name for the condition [5]. It is often helpful to seek care from a dermatologist who specializes in genetic skin disorders.
The Typical Disease Course
While every person’s experience with Mal de Meleda is unique, the condition generally follows a familiar timeline:
- Early Infancy: Thickening often begins at birth or within the first few months of life. It usually starts as redness and peeling on the palms and soles [1].
- Childhood: As the child grows, the skin becomes thicker and may take on a yellowish, waxy appearance. This is when the “transgrediens” nature often becomes visible, spreading to the backs of the fingers and toes [1].
- Adulthood: While the skin often continues to thicken, the extent and rate of progression vary. In some cases, the tightness of the skin and surrounding tissues can lead to contractures (persistent loss of joint movement caused by shortening or tightening of skin, fascia, tendons, muscles, or the joint capsule) or pseudoainhum (constriction bands that can form around fingers or toes) [1][6].
Beyond the thickening itself, common associated symptoms include hyperhidrosis (excessive sweating), which can lead to maceration (softened, white skin) and a distinct odor due to trapped moisture and bacterial growth in the thick skin [1][2].
Validating the Emotional Impact
Living with a visible, rare skin condition involves more than just physical symptoms. It is natural to feel a range of emotions, from relief at finally having a diagnosis to anxiety about the future.
- Social and Emotional Burden: Research shows that rare skin conditions can significantly impact quality of life, often leading to feelings of self-consciousness or social withdrawal [7][8].
- Pain and Function: Thickened skin can lead to painful fissures (deep cracks) that make walking or using your hands difficult [9]. This physical limitation can contribute to feelings of frustration or isolation [10].
Acknowledging these challenges is a vital part of your care. Many patients find that connecting with rare disease communities or seeking psychosocial support helps them navigate the social aspects of the condition while they work with their medical team on physical management [11].
Common questions in this guide
What do “transgrediens” and “progrediens” mean in Mal de Meleda?
How is Mal de Meleda passed through families?
What symptoms can Mal de Meleda cause?
How do doctors confirm a Mal de Meleda diagnosis?
Does Mal de Meleda get worse over time?
Which specialist can help manage Mal de Meleda?
Get notified when new evidence is published on Transgrediens et progrediens palmoplantar keratoderma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Mal de Meleda: A Focused Review.
Perez C, Khachemoune A
American journal of clinical dermatology 2016; (17(1)):63-70 doi:10.1007/s40257-015-0157-1.
PMID: 26445964 - 2
Atypical Mal de Meleda in a Hispanic Patient.
Guevara M, Mafla M, Miño C
Case reports in dermatological medicine 2023; (2023()):6640311 doi:10.1155/2023/6640311.
PMID: 37744084 - 3
A Mal De Meleda patient with severe flexion contractures of hands and feet: A case report in West China.
Pan Y, Zhao H, Chen A, Huang X
Medicine 2017; (96(36)):e7972 doi:10.1097/MD.0000000000007972.
PMID: 28885351 - 4
Identification of novel homozygous SLURP1 mutation in a Javanese family with Mal de Meleda.
Radiono S, Pramono ZAD, Oh GGK, et al.
International journal of dermatology 2017; (56(11)):1161-1168 doi:10.1111/ijd.13776.
PMID: 29023701 - 5
Atypical manifestation of psoriasis in the elderly: possible expression of Mal de Meleda diagnosis review and case report.
Onisor C, Sarpe AM, Niculet E
Frontiers in medicine 2025; (12()):1634843 doi:10.3389/fmed.2025.1634843.
PMID: 41048964 - 6
What's the resolutive surgery for pseudo-ainhum in Vohwinkel syndrome? A case report and review of the literature.
Rovere G, Stramazzo L, Cioffi A, et al.
Orthopedic reviews 2020; (12(4)):8868 doi:10.4081/or.2020.8868.
PMID: 33633820 - 7
Impact of Palmoplantar Dermatoses on Quality of Life.
Singhal R, Diwan NG, Nair PA
Indian dermatology online journal 2018; (9(5)):309-313 doi:10.4103/idoj.IDOJ_347_17.
PMID: 30258797 - 8
Mal de Meleda: A great imitator.
Bakija-Konsuo A, Zitinski M, Fatovic-Ferencic S
Clinics in dermatology 2019; (37(3)):175-181 doi:10.1016/j.clindermatol.2019.01.003.
PMID: 31178100 - 9
Pain mechanisms in hereditary palmoplantar keratodermas.
Weinberg RL, Coulombe PA, Polydefkis M, Caterina MJ
The British journal of dermatology 2020; (182(3)):543-551 doi:10.1111/bjd.17880.
PMID: 30883689 - 10
Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations.
Greco C, Leclerc-Mercier S, Chaumon S, et al.
JAMA dermatology 2020; (156(2)):191-195 doi:10.1001/jamadermatol.2019.4126.
PMID: 31895432 - 11
Transgradient Variant of Mal De Meleda Presenting As Palmoplantar Keratoderma: A Case Report.
Khan A, Singh A, Madke B, et al.
Cureus 2024; (16(5)):e60717 doi:10.7759/cureus.60717.
PMID: 38903266
This page is for informational purposes only and does not constitute medical advice about Mal de Meleda. A dermatologist or medical genetics professional can interpret your symptoms, genetic results, and care needs.